XWELL, Inc. (XWEL) - Dilution Analysis

10-Q filing | 8.4M shares outstanding

S-3 filing: This prospectus relates to the resale by the selling stockholders of up to an aggregate of 138,665,191 shares of XWELL, Inc.'s common stock, consisting of shares issuable upon conversion of preferred stock and shares issuable upon exercise of certain warrants.

10-Q filing | 5.8M shares outstanding

8-K filing: XWELL, Inc. entered into a Securities Exchange and Amendment Agreement with investors to exchange Series G Preferred Stock for senior secured convertible notes, amend warrant terms, and amend Series G Preferred Stock terms, pending stockholder approval.

10-Q filing | 5.4M shares outstanding

S-3/A filing: This prospectus relates to the resale by the selling stockholders of up to an aggregate of 30,440,060 shares of common stock issuable upon conversion of preferred shares, exercise of warrants, and issuance of common stock as dividends.

S-3/A filing: This S-3/A filing registers the resale of up to 32,703,889 shares of common stock by selling stockholders, issuable upon conversion of Series G preferred stock, exercise of warrants, and issuance of dividend shares.

10-Q filing | 5.3M shares outstanding

S-3/A filing: This prospectus relates to the resale of up to 62,003,579 shares of common stock by selling stockholders, issuable upon conversion of preferred shares, exercise of warrants, and issuance of dividend shares.

10-K filing | 5.3M shares outstanding

S-3 filing: XWELL, Inc. is offering 1,051,677 shares of common stock issuable upon conversion of preferred shares and exercise of warrants by selling stockholders.

8-K filing: XWELL, Inc. entered into a Securities Purchase Agreement to sell Series G Convertible Preferred Stock and warrants to accredited investors in a private placement that closed on January 14, 2025, resulting in gross proceeds of $4 million. ($4.0M proceeds)

10-Q filing | 4.8M shares outstanding

10-Q filing | 4.2M shares outstanding

8-K filing: XWELL, Inc. entered into a securities purchase agreement to sell 652,705 shares of common stock in a registered direct offering, expecting approximately $1.4 million in gross proceeds, and issued 416,000 shares of common stock to Settlor Parties in consideration for their entry into a Settlement Agreement. ($1.4M proceeds)

10-Q filing | 4.2M shares outstanding

10-K filing | 4.2M shares outstanding

10-Q filing | 4.2M shares outstanding

10-Q filing | 83.4M shares outstanding

S-3 filing: XWELL, INC. is filing an S-3 to offer up to $200,000,000 of any combination of common stock, preferred stock and debt securities.

10-Q filing | 83.3M shares outstanding

10-K filing | 83.2M shares outstanding

10-Q filing | 94.6M shares outstanding

10-Q filing | 95.4M shares outstanding

8-K filing: XpresSpa Group, Inc. authorized an increase in its stock repurchase program to purchase up to 10 million additional shares of its common stock, extending the authorization through September 15, 2023, bringing the total authorization to approximately 13.2 million shares.

S-3/A filing: This S-3/A filing relates to the resale of up to 4,696,134 shares of common stock by selling stockholders.

10-Q filing | 101.6M shares outstanding

S-3/A filing: This S-3/A filing relates to the resale of up to 4,696,134 shares of common stock by selling stockholders.

10-K filing | 104.3M shares outstanding

S-3 filing: Registration for resale of common stock by selling stockholders.

8-K filing: XpresSpa Group entered into an acquisition agreement to acquire HyperPointe, issuing 552,486 shares of common stock and potentially up to an additional 4,143,647 shares as earnout consideration, and agreed to issue options to purchase up to 1,000,000 shares of common stock to Ezra Ernst as an employment inducement award.

10-Q filing | 94.1M shares outstanding

8-K filing: XpresSpa Group, Inc. authorized a stock repurchase program for up to 15 million shares of its common stock, effective through September 15, 2022.

10-Q filing | 105.4M shares outstanding

10-Q filing | 105.3M shares outstanding

10-K filing | 105.3M shares outstanding

8-K filing: XpresSpa Group, Inc. completed a registered direct offering on December 21, 2020, issuing 24,509,806 shares of common stock and warrants to purchase 24,509,806 shares at a combined price of $1.70 per share, resulting in gross proceeds of approximately $41.7 million. ($41.7M proceeds)

8-K filing: XpresSpa Group, Inc. entered into securities purchase agreements to sell 24,509,806 shares of common stock and warrants to purchase up to 24,509,806 shares in a registered direct offering, with gross proceeds of approximately $41.66 million. ($41.66M proceeds)

10-Q filing | 69.5M shares outstanding

8-K filing: XpresSpa Group, Inc. entered into a Securities Purchase Agreement to issue and sell 10,407,408 shares of common stock and warrants exercisable for 11,216,932 shares at a combined offering price of $3.15 per share, along with pre-funded warrants to purchase 809,524 shares, resulting in gross proceeds of approximately $35.3 million before deducting fees and expenses. ($32.78M proceeds)

8-K filing: XpresSpa Group, Inc. completed a registered direct offering of 11,216,932 shares of common stock and warrants to purchase up to 11,216,932 shares of common stock at a combined purchase price of $3.15 per share and warrant, with gross proceeds of approximately $35.3 million. ($35.3M proceeds)

10-Q filing | 56.8M shares outstanding

S-3/A filing: This prospectus relates to the resale of up to an aggregate of 10,212,492 shares of our Common Stock.

S-3 filing: Xpresspa Group, Inc. files an S-3 form to register the offering of up to $200,000,000 in securities, including common stock, preferred stock and debt securities.

S-3 filing: This prospectus relates to the resale of up to an aggregate of 10,499,991 shares of our Common Stock including shares issuable upon the exercise of warrants and conversion of a promissory note.

10-Q filing | 56.5M shares outstanding

8-K filing: XpresSpa Group, Inc. entered into a Securities Purchase Agreement to issue and sell 7,614,700 shares of common stock at $5.253 per share in a registered direct offering, expecting gross proceeds of approximately $40.0 million, and also agreed to issue warrants for 7,614,700 shares of common stock at an exercise price of $5.25 per share in a concurrent private placement. ($40.0M proceeds)

8-K filing: Stock split 1-for-3 | Outstanding: 86,500,160 → 28,804,553

8-K filing: XpresSpa Group, Inc. entered into a Warrant Exchange Agreement with the holder of certain existing warrants to exchange the warrants for 6,186,377 shares of common stock.

8-K filing: XpresSpa Group, Inc. amended and restated a convertible note held by B3D, LLC to allow for direct conversion into common stock.

10-K filing | 86.5M shares outstanding

8-K filing: XpresSpa Group amended a securities purchase agreement with Calm.com, Inc. regarding convertible notes and warrants, adjusting conversion rights and beneficial ownership limitations.

8-K filing: XpresSpa Group, Inc. entered into a Securities Purchase Agreement to issue and sell 12,418,179 shares of common stock at $0.22 per share and 1,445,454 pre-funded warrants at $0.21 per Pre-Funded Warrant in a registered direct offering, expecting gross proceeds of approximately $3.05 million. ($3.04M proceeds)

8-K filing: XpresSpa Group, Inc. agreed to issue and sell 7,895,000 shares of common stock at $0.20 per share and 2,105,000 pre-funded warrants at $0.19 per warrant in a registered direct offering, expecting gross proceeds of approximately $2.0 million.

8-K filing: XpresSpa Group, Inc. entered into a Securities Purchase Agreement to issue and sell 7,450,000 shares of common stock at $0.20 per share and 1,500,000 pre-funded warrants at $0.19 per warrant, expecting gross proceeds of approximately $1.79 million. ($1.78M proceeds)

8-K filing: XpresSpa Group, Inc. entered into a Securities Purchase Agreement to issue and sell 4,153,383 shares of common stock at $0.175 per share and 2,132,333 pre-funded warrants at $0.165 per warrant in a registered direct offering, expecting gross proceeds of approximately $1.1 million, and also entered into Warrant Exchange Agreements to exchange existing warrants for new shares of common stock. ($1.08M proceeds)

8-K filing: XpresSpa Group, Inc. issued 291,669 shares of common stock to B3D, LLC in satisfaction of interest payable pursuant to the B3D Note for the months of October, November, and December 2020.